The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Francis J. Giles*, William T. Bellamy, Zeev Estrov, Susan M. O'Brien, Srdan Verstovsek, Farhad Ravandi, Miloslav Beran, Paul Bycott, Yazdi Pithavala, Heidi Steinfeldt, Steven D. Reich, Alan F. List, Karen W L Yee

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences

Pharmacology, Toxicology and Pharmaceutical Science